Cleocin Phosphate Injection, Solution
Product Images NDC 0009-0870

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Cleocin Phosphate (NDC 0009-0870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cleocin Solution 01)

Chemical structure diagram of Cleocin Phosphate (clindamycin phosphate) showing its atomic and molecular arrangement.*

FDA Label Image

Logo (Cleocin Solution 02)

FDA Label Image

Figure 1 And 2 (Cleocin Solution 03)

Illustration showing a two-step process of opening a bottle with a child-resistant cap. Fig. 1 depicts pressing and turning the cap, and Fig. 2 shows lifting the cap off the bottle. No text or branding visible.*

FDA Label Image

Figure 3 And 4 (Cleocin Solution 04)

Illustrations showing hands removing and replacing the cap on a bottle or container. The images demonstrate steps involved in handling or opening the container, likely related to Cleocin Phosphate 150 mg/mL packaging or use instructions.*

FDA Label Image

Figure 5 And 6 (Cleocin Solution 05)

Instructional illustrations showing hand techniques to open or operate a Cleocin Phosphate 150 mg/mL intravenous infusion bag. Fig. 5 and Fig. 6 demonstrate specific steps in handling the bag's closure or injection port, likely for medication preparation or administration.*

FDA Label Image

Principal Display Panel (300 mg/2 mL Vial Label)

FDA Label Image

Principal Display Panel (300 mg/2 mL Vial Carton)

Label for Cleocin Phosphate clindamycin injection USP, showing 300 mg per 2 mL (150 mg/mL) strength in a 2 mL single-dose vial. The label indicates storage instructions at controlled room temperature (20 to 25°C), warns not to refrigerate, and states use for intramuscular or intravenous administration. Distributed by Pharmacia & Upjohn Company LLC.*

FDA Label Image

Principal Display Panel (600 mg/4 mL Vial Label)

Packaging label for Cleocin Phosphate clindamycin injection, USP 300 mg/2 mL (150 mg/mL) in 25 single-dose 2 mL vials. The label indicates intramuscular or intravenous use. Distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. The label includes storage instructions and dosage warnings.*

FDA Label Image

Principal Display Panel (600 mg/4 mL Vial Carton)

Label for Cleocin Phosphate 600 mg/4 mL (150 mg/mL) clindamycin injection, USP in a 4 mL vial. Distributed by Pharmacia & Upjohn Company LLC, this single-dose container specifies controlled room temperature storage and dosing instructions. NDC 0009-0775-20 is shown.*

FDA Label Image

Principal Display Panel (900 mg/6 mL Vial Label)

Packaging label for Cleocin Phosphate clindamycin injection USP, 150 mg/mL strength, presented as 600 mg/4 mL, in 25 single-dose 4 mL vials. The label indicates Pfizer Injectables and the distributor as Pharmacia & Upjohn Company LLC, a division of Pfizer Inc. Instructions mention intramuscular or intravenous use and storage at controlled room temperature. The label design includes teal, black, and white colors with dosage and drug information prominently displayed.*

FDA Label Image

Principal Display Panel (900 mg/6 mL Vial Carton)

Label for Cleocin Phosphate clindamycin injection USP, 900 mg/6 mL (150 mg/mL) in a 6 mL vial. The label indicates storage instructions, dosage form, and is labeled for intramuscular or intravenous use. Manufactured by Pharmacia & Upjohn Company LLC with NDC 0009-0902-11.*

FDA Label Image

Principal Display Panel (9,000 mg/60 mL Vial Bulk Label)

Packaging label for Cleocin Phosphate clindamycin injection USP 900 mg/6 mL (150 mg/mL) by Pharmacia & Upjohn Company LLC. The label indicates 25 single-dose vials of 6 mL each for intramuscular or intravenous use. The Pfizer logo is present along with storage instructions and content warnings.*

FDA Label Image

Principal Display Panel (9,000 mg/60 mL Vial Bulk Carton)

Label for Cleocin Phosphate clindamycin injection USP, 9,000 mg per 60 mL (150 mg/mL) in a 60 mL pharmacy bulk package. The label includes storage instructions to keep at controlled room temperature and to avoid refrigeration. It contains dosage information, warnings, and directions for dilution and usage. Distributed by Pharmacia & Upjohn Company LLC, a division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (600 mg/4 mL Vial Label)

Package label for Cleocin Phosphate 150 mg/mL injection by Pharmacia & Upjohn Company LLC. It shows the total dose as 9,000 mg per 60 mL vial intended for intramuscular or intravenous use, not for direct infusion. The label features Pfizer Injectables branding with dosing, storage, and manufacturing details prominently displayed on a purple and black design.*

FDA Label Image

Principal Display Panel (600 mg/4 mL ADD-Vantage Vial Carton)

Label for Cleocin Phosphate 600 mg/4 mL (150 mg/mL) clindamycin injection, USP, a single dose 4 mL ADD-Vantage vial. The label includes storage instructions, dosage guidance, and distribution information by Pharmacia & Upjohn Company LLC, with branding for Pfizer Injectables.*

FDA Label Image

Principal Display Panel (900 mg/6 mL Vial Label)

Box packaging label for Cleocin Phosphate clindamycin injection USP 600 mg/4 mL (150 mg/mL) in 25 single-dose ADD-Vantage vials. The label shows the Pfizer Injectables logo and states it is for intravenous use only. Distributed by Pharmacia & Upjohn Company LLC, with storage instructions and warning for dilution before use. The design includes teal and black color blocks with dosage and NDC codes.*

FDA Label Image

Principal Display Panel (900 mg/6 mL ADD-Vantage Vial Carton)

Cleocin Phosphate 900 mg/6 mL (150 mg/mL) vial label for clindamycin injection, USP. The label states it is for intravenous use only and to use with the ADD-Vantage diluent container. It is a single-dose 6 mL ADD-Vantage vial distributed by Pharmacia & Upjohn Company LLC, with storage instructions to keep at 20° to 25°C and not refrigerate. The label features the Pfizer and Injectables logos.*

FDA Label Image

Principal Display Panel (300 mg/ 50 mL Container Label)

Packaging label for Cleocin Phosphate clindamycin injection, USP, 900 mg/6 mL (150 mg/mL) for intravenous use only. The label indicates 25 single-dose 6 mL ADD-Vantage vials. The labeler is Pharmacia & Upjohn Company LLC, distributed by Pfizer Inc. The design includes green and black color accents with the Pfizer Injectables logo.*

FDA Label Image

Principal Display Panel (300 mg/ 50 mL Container Carton)

Label for Cleocin Phosphate IV Solution, clindamycin injection, 300 mg/50 mL in 5% dextrose. The label states it is for intravenous use only, supplied in a sterile, nonpyrogenic single dose GALAXY container. It includes storage instructions, manufacturer and distributor details: Pharmacia & Upjohn Company LLC and Pfizer Inc. The label also features a barcode and regulatory information.*

FDA Label Image

Principal Display Panel (600 mg/ 50 mL Container Label)

Label for Cleocin Phosphate IV Solution, 300 mg/50 mL in 5% Dextrose, clindamycin injection. The product is supplied in single-dose containers with a package size indicating 2 boxes of 12 x 50 mL. Labeler shown is Pharmacia & Upjohn Company LLC, manufactured by Pfizer Inc. The label includes storage instructions and cautions regarding usage and container integrity.*

FDA Label Image

Principal Display Panel (600 mg/ 50 mL Container Carton)

Label for Cleocin Phosphate IV Solution, clindamycin injection, with a concentration of 600 mg/50 mL in 5% dextrose. The label specifies intravenous use, sterile and nonpyrogenic single-dose container, and provides storage and usage cautions. Distributed by Pharmacia & Upjohn Company LLC, division of Pfizer Inc.*

FDA Label Image

Principal Display Panel (900 mg/ 50 mL Container Label)

Label for Cleocin Phosphate IV Solution 600 mg/50 mL (equivalent to 150 mg/mL clindamycin), injection in 5% Dextrose. The product is supplied in 2 x 12 x 50 mL single-dose containers, distributed by Pharmacia & Upjohn Company LLC, Division of Pfizer Inc. The label includes instructions and cautions regarding use and storage.*

FDA Label Image

Principal Display Panel (900 mg/ 50 mL Container Carton)

Label for Cleocin Phosphate IV Solution, clindamycin injection, 900 mg per 50 mL in 5% dextrose. The label specifies intravenous use and includes storage instructions, dosage warnings, and manufacturer information. Distributed by Pharmacia & Upjohn Company LLC, Pfizer Injectables, with barcode and NDC 0009-3382-01.*

FDA Label Image

Principal Display Panel (300 mg/2 mL ADD-vantage Vial Label)

Label for Cleocin Phosphate 900 mg/50 mL intravenous (IV) solution in 5% dextrose, injection form. The label indicates packaging in 2 boxes of 12 single-dose 50 mL containers. Distributed by Pharmacia & Upjohn Company LLC, Pfizer labeler. Includes storage recommendations and cautions for use.*

FDA Label Image

Principal Display Panel (300 mg/2 mL ADD-Vantage Vial Carton)

Label for Cleocin Phosphate 150 mg/mL clindamycin injection, USP in a 2 mL single-dose ADD-Vantage vial. The label states the concentration as 300 mg per 2 mL and indicates it is for intravenous use only. The labeler is Pharmacia & Upjohn Company LLC, a Pfizer company.*

FDA Label Image

Cleocin Solution 26

Packaging label for Cleocin Phosphate clindamycin injection, USP 300 mg/2 mL (150 mg/mL) by Pharmacia & Upjohn Company LLC, a Pfizer division. The label indicates 25 single-dose 2 mL ADD-Vantage vials, for intravenous use only. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.